Radiographic progression in non-radiographic axial spondyloarthritis

Expert Rev Clin Immunol. 2018 Jun;14(6):525-533. doi: 10.1080/1744666X.2018.1477591. Epub 2018 May 24.

Abstract

Non-radiographic axial spondyloarthritis (nr-axSpA) represents a subtype of axial spondyloarthritis (axSpA) with no significant structural damage in sacroiliac joints and spine. In addition, patients with nr-axSpA demonstrate a substantial burden of illness, and a considerable share of them might progress to radiographic axSpA (r-axSpA) over time. The amount and quality of published data allows crude estimation of progression rate and factors related to a higher risk of progression. Areas covered: This review discusses the available data reporting the rates and predictors of radiographic progression in the sacroiliac joints and in the spine in patients with nr-axSpA as well as predisposing factors for such a progression. Expert commentary: Most of the studies report about 10-40% of patients with nr-axSpA to progress to r-axSpA over a period of 2-10 years. Multiple risk factors for the radiographic sacroiliitis progression are outlined and explored. There are not enough data to presume that any treatment modality may influence progression from nr-axSpA to r-axSpA, with TNFi showing some promising results. Radiographic progression in the spine is in general low in nr-axSpA; thus, long-term studies are required to investigate the natural course of the progression and possible treatment effects.

Keywords: Axial spondyloarthritis; ankylosing spondylitis; non-radiographic axial spondyloarthritis; progression; radiographic axial spondyloarthritis; radiographic progression.

Publication types

  • Review

MeSH terms

  • Disease Progression
  • Humans
  • Spondylarthritis / pathology*